Literature DB >> 23303885

Androgen deprivation treatment in prostate cancer.

Benjamin C Thomas1, David E Neal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23303885     DOI： 10.1136/bmj.e8555

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  6 in total

1.  Inadequate testosterone suppression after medical and subsequent surgical castration in a patient with prostate cancer.

Authors:  Oskar Ragnarsson; Gudmundur Johannsson; Kjell Geterud; Par Lodding; Per Dahlqvist
Journal:  BMJ Case Rep       Date:  2013-08-13

Review 2.  Emerging potential of parenteral estrogen as androgen deprivation therapy for prostate cancer.

Authors:  Syed Imran Ali Shah
Journal:  South Asian J Cancer       Date:  2015 Apr-Jun

Review 3.  Androgen receptors beyond prostate cancer: an old marker as a new target.

Authors:  Javier Munoz; Jennifer J Wheler; Razelle Kurzrock
Journal:  Oncotarget       Date:  2015-01-20

4.  Psychosexual experiences of men following radiotherapy for prostate cancer in Johannesburg, South Africa.

Authors:  Matheko N Phahlamohlaka; Sibusiso Mdletshe; Heather Lawrence
Journal:  Health SA       Date:  2018-10-09

5.  Congenital Adrenal Hyperplasia Causing Poor Response to Androgen Deprivation Therapy in Prostate Cancer.

Authors:  Mustafa Kinaan; Oksana Hamidi; Hanford Yau; Kevin D Courtney; Akin Eraslan; Kenneth Simon
Journal:  J Endocr Soc       Date:  2020-10-23

6.  Androgen Deprivation Therapy and the Re-emergence of Parenteral Estrogen in Prostate Cancer.

Authors:  Iain Phillips; Syed I A Shah; Trinh Duong; Paul Abel; Ruth E Langley
Journal:  Oncol Hematol Rev       Date:  2014
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.